Skip to content

Drug interactions

Infliximab + Ofatumumab sc

Severity: Major

Infliximab and Ofatumumab sc: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ofatumumab depletes B cells and infliximab blocks TNF, so combining them may increase the risk of serious infections. Switching between such therapies also requires attention to residual immune effects.

What this interaction means in plain words

Infliximab and Ofatumumab sc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Low

Why it happens

Additive immunosuppression via B-cell depletion and TNF-alpha inhibition.

What to do

Avoid concurrent use where possible and monitor for infection. When switching, allow for the duration of effect of the earlier drug.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Infliximab and Ofatumumab sc, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Infliximab with Ofatumumab sc?

MediHelp rates the interaction as major. Infliximab and Ofatumumab sc can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ofatumumab depletes B cells and infliximab blocks TNF, so combining them may increase the risk of serious infections. Switching between such therapies also requires attention to residual immune effects.

How serious is the interaction between Infliximab and Ofatumumab sc?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid concurrent use where possible and monitor for infection. When switching, allow for the duration of effect of the earlier drug.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in